"Concerning": Myocarditis Diagnoses Spiked In Military in 2021, New Data Show
…
Johnson & Johnson stock falls Wednesday, underperforms market...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock remains steady Tuesday, underperforms market...…
Even if we look at a longer time frame, AbbVie fares better, with its sales rising at an average annual…
Johnson & Johnson stock rises Monday, outperforms market...…
Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix are part of the Zacks top Analyst Blog....…
Close to its 52-week low, this healthcare stalwart remains a good purchase....…
Johnson & Johnson stock falls Friday, still outperforms market...…
Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM)…
read more...…
Johnson & Johnson stock underperforms Thursday when compared to competitors...…
Johnson & Johnson stock outperforms market on strong trading day...…
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Johnson & Johnson stock rises Tuesday, still underperforms market...…
Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains...…
J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article....…
Kellogg, Johnson & Johnson, Crane, and BorgWarner are planning to hive off a chunk of their businesses in 2023. What…
Johnson & Johnson stock falls Thursday, still outperforms market...…
Johnson & Johnson stock falls Wednesday, underperforms market...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock outperforms market despite losses on the day...…
Protagonist Therapeutics Sees Positive Topline Results in JNJ-2113 Trial...…
In the latest trading session, Johnson & Johnson (JNJ) closed at $155.56, marking a +1% move from the previous day....…
Johnson & Johnson stock rises Monday, outperforms market...…
Kenvue Inc., the consumer products spinoff from Johnson & Johnson JNJ, has grown the roster of banks underwriting its initial…
Johnson & Johnson stock rises Friday, still underperforms market...…
Johnson & Johnson stock underperforms Thursday when compared to competitors...…
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Johnson & Johnson stock falls Wednesday, still outperforms market...…
New York (www.aktiencheck.de) - Rating-Update:
Vamil Divan, Analyst von Guggenheim Securities, startet die Coverage der Aktie von Johnson & Johnson (J&J)…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson (JNJ) closed the most recent trading day at $153.26, moving -1.52% from the previous trading session....…
Johnson & Johnson stock underperforms Tuesday when compared to competitors...…
Johnson & Johnson stock falls Monday, underperforms market...…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Johnson & Johnson stock falls Friday, underperforms market...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock outperforms competitors despite losses on the day...…
Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…
Johnson & Johnson (JNJ) closed the most recent trading day at $157.78, moving -0.14% from the previous trading session....…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
But making Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in…
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…
NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
Bangalore (Reuters) - Die Consumer-Health-Sparte mit rezeptfreien Medikamenten und anderen Gesundheitsprodukten des US-Pharmakonzerns Johnson & Johnson (J&J) hat einen Antrag…
NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…
NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…